Opdivo Safe for Head and Neck Cancer Patients on Radiation and Chemo, Phase 1 Trial Shows
News
Adding Bristol-Myers-Squibb‘s Opdivo (nivolumab) to a regimen of radiation therapy and chemotherapy is safe in patients with newly diagnosed advanced head and neck cancer, a Phase 1 clinical trial shows. Researchers presented ... Read more